Author

Qingxin Yu

Observed name: Yu, Qing-xin

Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital, Zhejiang University

Observed institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital, Ningbo Medical Center Lihuili Hospital, Zhejiang University

OpenAlex ID: A5111276762

The complex interplay of tumor-infiltrating cells in driving therapeutic resistance pathways

2024 · Dengxiong Li, Fanglin Shao, et al. · Cell Communication and Signaling · 31

Targeting Prolyl 4-Hydroxylase Subunit Beta (P4HB) in Cancer: New Roads to Travel

2023 · Dechao Feng, Jie Wang, et al. · Aging and Disease · 14

The application of 3D printing technology in tumor radiotherapy in the era of precision medicine

2024 · Chao Jiang, Zhiwei Jiang, et al. · Applied Materials Today · 12

Decoding the crossroads of aging and cancer through single‐cell analysis: Implications for precision oncology

2025 · Dengxiong Li, Qingxin Yu, et al. · International Journal of Cancer · 7

Pseudouridine synthase 7 (PUS7) affects the prognosis and immune modulation of patients with bladder cancer

2024 · Duohui Li, Liang Wu, et al. · Asian Journal of Surgery · 2

Next‐Generation Surgery: Integrating Artificial Intelligence, Genetic Technologies, Bioengineering and Rehabilitation Into Modern Practices

2026 · Dengxiong Li, Jie Wang, et al. · Exploration · 1

Pan-cancer analysis of m1A writer gene RRP8: implications for immune infiltration and prognosis in human cancers

2024 · Zhihui Huang, Koo Han Yoo, et al. · Discover Oncology · 1

Works count: 10

Citation count: 68

H-index: 4

I10-index: 3